Delivery Order SPE2DB25D9312-SPE2DB25FWUWE
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $97,499.70 by the Defense Logistics Agency's Medical Supply Chain on July 15, 2025. The delivery order, which is expected to be completed by August 5, 2025, calls for the supply of Stelara 90 mg/mL syringes to support federal healthcare operations. This award was issued under DMS Pharmaceutical Group's existing single-award...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) on July 17, 2025. The contract calls for delivery of Stelara 90 mg/ml syringes, a biologic medication used to treat immunological conditions, with an ultimate completion date of August 7, 2025. This delivery order carries no set-aside designation and will be performed at the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on August 12, 2025. The delivery order, which is expected to be completed by September 3, 2025, covers the supply of Stelara 90 mg/ml syringes to support Department of Defense healthcare facilities. This award was issued without a set-aside designation, demonstrating the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) on June 3, 2025. The delivery order, which carries an ultimate completion date of June 25, 2025, covers the supply of Stelara 90 mg/ml syringes for distribution to military healthcare facilities. This award was issued without a set-aside designation, allowing the vendor to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $48,749.85 by the Defense Logistics Agency on September 12, 2025, for the supply of Stelara 90 mg/ml syringes. The contract contains no set-aside designation and is scheduled for completion by October 3, 2025, with performance taking place at the awardee's Park Ridge facility. This delivery order is issued under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $65K by the Defense Logistics Agency on September 5, 2025, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order is expected to be completed by September 26, 2025, and represents a continuation of the company's ongoing pharmaceutical supply relationship with the federal government. The award carries no set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency for Stelara 90 mg/ml syringes. The contract was awarded on September 24, 2025, with an ultimate completion date of October 16, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) on October 3, 2025. The contract, with an ultimate completion date of October 27, 2025, calls for the delivery of Stelara 90 mg/ml syringes to support federal healthcare requirements. This award was issued without a set-aside designation, demonstrating the company's competitive...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 24, 2025, for Stelara 90 mg/ml syringes valued at $32,499.90. This firm fixed-price delivery order, which is set to be completed by August 14, 2025, was issued without a set-aside designation, allowing the contractor to compete on an unrestricted basis. The award falls under DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $32,499.90 on August 13, 2025, by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, which is scheduled for completion by September 4, 2025, represents a continuation of the company's substantial role as a critical supplier within the federal pharmaceutical supply chain. The...
- SPE2DB25D9312Indefinite Delivery Contract
- SPE2DB25D9312-SPE2DB25FWUWEDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $97,499.70 by the Defense Logistics Agency on September 5, 2025, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, with an ultimate completion date of September 26, 2025, carries no set-aside designation and represents one of many pharmaceutical product deliveries issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The company leverages its status as a woman-owned small business to compete effectively in federal procurement markets while maintaining a comprehensive inventory of branded and generic prescription drugs, biologics, and medical consumables for military and federal healthcare facilities. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract valued at $499,999,999 and valid through November 2026 under the DLA's SPE2DB program, which enables the issuance of firm fixed-price delivery orders for pharmaceutical items supporting medical supply needs of military health facilities worldwide. Through this framework contract, the company supplies an extensive portfolio of pharmaceutical products across multiple categories, establishing itself as a crucial supplier in the federal pharmaceutical supply chain with direct distribution capabilities to Department of Defense healthcare sites nationally and internationally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $97.5k | 9/5/25 |